Bright Minds Biosciences (DRUG) Non-Current Assets (2020 - 2026)
Bright Minds Biosciences (DRUG) posted Non-Current Assets of $52778.4 for Q1 2026, down 20.15% on a QoQ basis from $66100.3 in Q4 2025, and down 50.99% year-over-year from $107682.7 in Q1 2025.
Bright Minds Biosciences (DRUG) Non-Current Assets (2020 - 2026) Analysis & Trends
Bright Minds Biosciences' Non-Current Assets history runs 7 years deep, the most recent figure standing at $52778.4 for Q1 2026.
- Quarterly Non-Current Assets fell 50.99% year-over-year to $52778.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $293322.2 (down 10.97% YoY) and the FY2025 annual result came in at $81359.9, down 5.67% from the prior year.
- Non-Current Assets was $52778.4 for Q1 2026 at Bright Minds Biosciences, down from $66100.3 in the prior quarter.
- Across five years, Non-Current Assets topped out at $126700.3 in Q4 2024 and bottomed at $8828.5 in Q2 2024.
- A 5-year average of $70965.3 and a median of $75921.0 in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 6601.37% — and 2024, when it sank 85.97%.
- Bright Minds Biosciences' Non-Current Assets stood at $88957.6 in 2022, then slumped by 60.12% to $35478.1 in 2023, then surged by 257.12% to $126700.3 in 2024, then sank by 47.83% to $66100.3 in 2025, then dropped by 20.15% to $52778.4 in 2026.
- Business Quant data shows DRUG's Non-Current Assets at $52778.4 in Q1 2026, $66100.3 in Q4 2025, and $81359.9 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Bright Minds Biosciences | 498.53 Mn | 498.53 Mn | - | 52,778.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52,778.45 |
| Dec 31, 2025 | 66,100.30 |
| Sep 30, 2025 | 81,359.87 |
| Jun 30, 2025 | 93,083.59 |
| Mar 31, 2025 | 107,682.66 |
| Dec 31, 2024 | 126,700.29 |
| Sep 30, 2024 | 86,249.60 |
| Jun 30, 2024 | 8,828.52 |
| Mar 31, 2024 | 22,402.91 |
| Dec 31, 2023 | 35,478.07 |
| Sep 30, 2023 | 49,539.48 |
| Jun 30, 2023 | 62,924.84 |
| Mar 31, 2023 | 75,920.96 |
| Dec 31, 2022 | 88,957.62 |
| Sep 30, 2022 | 106,472.68 |
| Sep 30, 2021 | 1,588.82 |
| Sep 30, 2020 | 1,500.85 |